PGY insider files Form 144 for 15,026 shares; recent sales totaled ~27,691 shares
Rhea-AI Filing Summary
Form 144 filed for Pagaya Technologies Ltd. (PGY) reports a proposed sale of 15,026 common shares by or for an insider through Morgan Stanley Smith Barney, with an aggregate market value of $446,121.94 and an approximate sale date of 10/01/2025 on NASDAQ. The shares were acquired as Restricted Stock Units (RSUs) on 06/12/2025 and paid on that date.
The filing also lists prior sales by the same person during the past three months: 7/03/2025 sale of 13,821 shares for $302,028.93, and two 9/15/2025 sales totaling 13,870 shares for combined gross proceeds of $571,448.94. The filer certifies they are not aware of undisclosed material adverse information and, if applicable, references any Rule 10b5-1 trading plan.
Positive
- Regulatory compliance: The filer provided required Form 144 details including broker, number of shares, market value, and acquisition information.
- Shares acquired as RSUs: The securities to be sold were acquired on 06/12/2025 as Restricted Stock Units, indicating compensation-related origin rather than an external purchase.
Negative
- Insider selling activity: Proposed sale of 15,026 shares and recent sales of 27,691 shares in the past three months are reported, totaling 42,717 shares transacted or planned.
- Significant gross proceeds reported: Recent sales generated approximately $873,477.87 in gross proceeds, which may be interpreted by some investors as insider liquidity.
Insights
TL;DR: Routine insider sale of recently vested RSUs; disclosure shows modest proceeds relative to typical corporate volumes.
The filing documents a proposed sale of 15,026 shares acquired as RSUs on 06/12/2025, with an indicated market value of $446,121.94 and an intended sale through Morgan Stanley on NASDAQ. Recent executed sales totaling 27,691 shares over July and September generated approximately $873,477.87 in gross proceeds. This pattern is consistent with monetizing compensation awards rather than extraordinary corporate events. No earnings, restructuring, or material nonpublic information is disclosed in the form.
TL;DR: Disclosure appears complete and compliant; repeated sales suggest routine insider liquidity, possibly under a trading plan.
The Form 144 includes required details: class, broker, number of shares, acquisition date and nature (RSUs), and recent sales history. The filer affirms absence of undisclosed material adverse information and references potential reliance on Rule 10b5-1 practices for prior sales. From a governance perspective, the filing meets regulatory transparency expectations for insider dispositions.